中西医结合治疗缺血性进展性卒中临床研究  

Integration of traditional Chinese and Western Medicine in Ischemic Progressive Stroke:A Clinical Research

作　　者：吴玉芙[1] 刘晓红[1] 郭伟成[1] 赵杰[1] 王浩然[1] 

机构地区：[1]北京老年医院卒中病房,北京100095

出　　处：《世界中医药》2017年第7期1601-1603,共3页World Chinese Medicine

基　　金：首都卫生发展科研专项批准项目(首发2016-1-2194)

摘　　要：目的:观察中西医结合治疗缺血性进展性卒中的临床疗效。方法:将220例进展性卒中患者分为中西医结合治疗组(观察组)与西医治疗组(对照组),每组110例。观察组在西医治疗的基础上根据中医辨证给予中药治疗,对照组给予西医治疗。结果:观察组愈显率92.7%,对照组愈显率81.8%。观察组疗效优于对照组(P<0.05)。观察组治疗后第7天、第14天、第21天NIHSS评分较治疗前均降低,观察组降低程度优于对照组(P<0.05)。结论:缺血性进展性卒中在西医规范化治疗的基础上进行中医辨证治疗可明显提高临床疗效。Objective： To observe the clinical effect of integrated traditional Chinese and western medicine in ischemic progressive stroke. Methods： All 220 patients with progressive stroke were divided into an integrated traditional Chinese and Western medicine treatment group and a western medicine group,110 patients in each. The treatment group was given Chinese medicine based on western medicine treatment according to syndrome differentiation of traditional Chinese medicine. The control group was given western medicine treatment. Results： The effective rate was 92. 7% in the treatment group,81. 8% in the control group. The treatment group was better than the control group（ P〈0. 05）. The 7th,14 th and 21 st days＇ NIHSS score after treatment all reduced in the treatment group,which decreased more than those of the control group. Conclusion： Differentiated TCM treatment based on standardized can significantly improve the clinical efficacy of Ischemic progressive stroke.

关 键 词：中西医结合 脑梗死 进展性卒中 临床疗效 

分 类 号：R255.2[医药卫生—中医内科学]